GlassScriptPhysician profile
Paul M Derber
NPI 1366446809
$1,108.22
in general payments reported to CMS, 2019-2025
18 companies · $97.81 in 2025
The $97.81 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.67 · 2021: $114 · 2022: $377 · 2023: $349 · 2024: $156 · 2025: $97.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $394.11 | 2021-2023 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $344.98 | 2021-2025 | Ozempic, Rybelsus, Tresiba |
| Idorsia Pharmaceuticals US INC | $44.78 | 2022-2023 | Quviviq |
| Amgen INC. | $33.97 | 2023 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $33.39 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Glaxosmithkline, LLC. | $27.87 | 2021-2024 | Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.61 | 2019-2022 | |
| Abbott Laboratories | $23.65 | 2025 | Freestyle Libre 3 |
| Stryker Corporation | $21.79 | 2025 | Clottriever Bold Catheter |
| Jazz Pharmaceuticals INC. | $21.60 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.90 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $18.33 | 2024 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $17.74 | 2024 | Farxiga |
| Astellas Pharma US INC | $17.66 | 2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $16.30 | 2023 | Eliquis |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.91 | 2023 | Watchman Flx |
| Takeda Pharmaceuticals U.S.A., INC. | $15.41 | 2021 | |
| Antares Pharma, INC. | $15.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Derber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.